BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25521594)

  • 1. A retrospective analysis of 141 patients with liver metastases from uveal melanoma: a two-cohort study comparing transarterial chemoembolization with CPT-11 charged microbeads and historical treatments.
    Valpione S; Aliberti C; Parrozzani R; Bazzi M; Pigozzo J; Midena E; Pilati P; Campana LG; Chiarion-Sileni V
    Melanoma Res; 2015 Apr; 25(2):164-8. PubMed ID: 25521594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and toxicity of transarterial chemoembolization therapy using cisplatin and gelatin sponge in patients with liver metastases from uveal melanoma in an Asian population.
    Shibayama Y; Namikawa K; Sone M; Takahashi A; Tsutsumida A; Sugawara S; Arai Y; Aihara Y; Suzuki S; Nakayama J; Imafuku S; Yamazaki N
    Int J Clin Oncol; 2017 Jun; 22(3):577-584. PubMed ID: 28144882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-arterial hepatic chemoembolization (TACE) of liver metastases from ocular melanoma with slow-release irinotecan-eluting beads. Early results of a phase II clinical study.
    Fiorentini G; Aliberti C; Del Conte A; Tilli M; Rossi S; Ballardini P; Turrisi G; Benea G
    In Vivo; 2009; 23(1):131-7. PubMed ID: 19368137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transarterial Chemoembolization of Liver Metastases from Uveal Melanoma Using Irinotecan-Loaded Beads: Treatment Response and Complications.
    Carling U; Dorenberg EJ; Haugvik SP; Eide NA; Berntzen DT; Edwin B; Dueland S; Røsok B
    Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1532-41. PubMed ID: 25832764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fotemustine chemoembolization of hepatic metastases from uveal melanoma: a retrospective single-center analysis.
    Edelhauser G; Schicher N; Berzaczy D; Beitzke D; Höeller C; Lammer J; Funovics M
    AJR Am J Roentgenol; 2012 Dec; 199(6):1387-92. PubMed ID: 23169735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uveal Melanoma Metastatic to the Liver: Chemoembolization With 1,3-Bis-(2-Chloroethyl)-1-Nitrosourea.
    Gonsalves CF; Eschelman DJ; Thornburg B; Frangos A; Sato T
    AJR Am J Roentgenol; 2015 Aug; 205(2):429-33. PubMed ID: 25905562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival.
    Vogl T; Eichler K; Zangos S; Herzog C; Hammerstingl R; Balzer J; Gholami A
    J Cancer Res Clin Oncol; 2007 Mar; 133(3):177-84. PubMed ID: 17021903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial chemoembolization of liver metastases from uveal melanoma after failure of systemic therapy: toxicity and outcome.
    Schuster R; Lindner M; Wacker F; Krössin M; Bechrakis N; Foerster MH; Thiel E; Keilholz U; Schmittel A
    Melanoma Res; 2010 Jun; 20(3):191-6. PubMed ID: 20335820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing the treatment of liver metastases from uveal melanomas with transarterial chemoembolization using melphalan and calibrated microspheres.
    Carle X; Gastaud L; Salleron J; Tardy MP; Caujolle JP; Thyss A; Thariat J; Chevallier P
    Bull Cancer; 2020 Dec; 107(12):1274-1283. PubMed ID: 33183739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive impact of the inflammation-based indices in uveal melanoma liver metastases treated with transarterial hepatic chemoperfusion.
    Ludwig JM; Haubold J; Bauer S; Richly H; Siveke JT; Wimmer J; Umutlu L; Schaarschmidt BM; Theysohn JM
    Radiol Oncol; 2021 May; 55(3):347-353. PubMed ID: 34051707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors of liver metastases from uveal melanoma.
    Kodjikian L; Grange JD; Baldo S; Baillif S; Garweg JG; Rivoire M
    Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):985-93. PubMed ID: 15891893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial chemoembolization with drug-eluting beads preloaded with irinotecan as a first-line approach in uveal melanoma liver metastases: tumor response and predictive value of diffusion-weighted MR imaging in five patients.
    Venturini M; Pilla L; Agostini G; Cappio S; Losio C; Orsi M; Ratti F; Aldrighetti L; De Cobelli F; Del Maschio A
    J Vasc Interv Radiol; 2012 Jul; 23(7):937-41. PubMed ID: 22720894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transarterial chemoembolization of liver metastases in patients with uveal melanoma.
    Huppert PE; Fierlbeck G; Pereira P; Schanz S; Duda SH; Wietholtz H; Rozeik C; Claussen CD
    Eur J Radiol; 2010 Jun; 74(3):e38-44. PubMed ID: 19467811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic metastasis from uveal melanoma: angiographic pattern predictive of survival after hepatic arterial chemoembolization.
    Dayani PN; Gould JE; Brown DB; Sharma KV; Linette GP; Harbour JW
    Arch Ophthalmol; 2009 May; 127(5):628-32. PubMed ID: 19433711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response, survival, and prognostic factors after hepatic arterial chemoembolization in patients with liver metastases from cutaneous melanoma.
    Ahrar J; Gupta S; Ensor J; Ahrar K; Madoff DC; Wallace MJ; Murthy R; Tam A; Hwu P; Bedikian AY
    Cancer Invest; 2011 Jan; 29(1):49-55. PubMed ID: 21166498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors.
    Bedikian AY; Legha SS; Mavligit G; Carrasco CH; Khorana S; Plager C; Papadopoulos N; Benjamin RS
    Cancer; 1995 Nov; 76(9):1665-70. PubMed ID: 8635073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial chemoembolization using DEBIRI for treatment of hepatic metastases from colorectal cancer.
    Narayanan G; Barbery K; Suthar R; Guerrero G; Arora G
    Anticancer Res; 2013 May; 33(5):2077-83. PubMed ID: 23645758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
    Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transarterial hepatic chemoperfusion of uveal melanoma metastases: survival and response to treatment.
    Heusner TA; Antoch G; Wittkowski-Sterczewski A; Ladd SC; Forsting M; Verhagen R; Scheulen M
    Rofo; 2011 Dec; 183(12):1151-60. PubMed ID: 22033849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative transarterial chemoembolization and resection for hepatocellular carcinoma: a nationwide Taiwan database analysis of long-term outcome predictors.
    Shi HY; Wang SN; Wang SC; Chuang SC; Chen CM; Lee KT
    J Surg Oncol; 2014 Apr; 109(5):487-93. PubMed ID: 24293372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.